1244 ET - This year's cough, cold and flu season isn't living up to Helen of Troy's expectations. "The global illness season will be well below historical averages," CFO Brian Grass says on a call with analysts. The company--with a portfolio that includes healthcare and home-comfort products such as Honeywell humidifiers and Vicks thermometers, as well as houseware brands Hydro Flask and OXO--lowered its outlook, in part due to a $15-million to $20-million headwind it expects in 4Q from the weak winter and illness season globally. "While there is the possibility that illness incidents could increase, we do not expect retailers to place meaningful, incremental replenishment orders as we are now roughly midway through the season," Grass says. Shares fall 4.8%. (connor.hart@wsj.com)
(END) Dow Jones Newswires
January 08, 2025 12:44 ET (17:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。